Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
40.01
Dollar change
+1.36
Percentage change
3.52
%
IndexRUT P/E15.46 EPS (ttm)2.59 Insider Own28.07% Shs Outstand48.07M Perf Week0.98%
Market Cap1.96B Forward P/E9.60 EPS next Y4.17 Insider Trans-3.28% Shs Float35.15M Perf Month-9.13%
Income137.54M PEG0.68 EPS next Q0.78 Inst Own67.31% Short Float10.45% Perf Quarter-27.31%
Sales644.39M P/S3.03 EPS this Y9.00% Inst Trans-2.06% Short Ratio8.41 Perf Half Y-15.23%
Book/sh13.30 P/B3.01 EPS next Y15.14% ROA12.20% Short Interest3.67M Perf Year-7.43%
Cash/sh5.30 P/C7.54 EPS next 5Y22.60% ROE23.55% 52W Range35.62 - 67.66 Perf YTD-35.31%
Dividend Est.- P/FCF13.45 EPS past 5Y- ROI10.93% 52W High-40.87% Beta0.87
Dividend TTM- Quick Ratio1.70 Sales past 5Y17.24% Gross Margin53.38% 52W Low12.32% ATR (14)1.32
Dividend Ex-Date- Current Ratio2.17 EPS Y/Y TTM50.98% Oper. Margin30.99% RSI (14)37.16 Volatility3.88% 2.64%
Employees1761 Debt/Eq0.98 Sales Y/Y TTM29.14% Profit Margin21.34% Recom1.83 Target Price62.60
Option/ShortYes / Yes LT Debt/Eq0.97 EPS Q/Q4.03% Payout0.00% Rel Volume0.94 Prev Close38.65
Sales Surprise2.70% EPS Surprise-3.25% Sales Q/Q31.91% EarningsFeb 28 AMC Avg Volume436.98K Price40.01
SMA20-4.24% SMA50-13.89% SMA200-23.15% Trades Volume410,091 Change3.52%
Date Action Analyst Rating Change Price Target Change
Mar-05-24Initiated JP Morgan Overweight $60
Nov-17-23Initiated BofA Securities Neutral $63
Jul-25-23Resumed Jefferies Buy $70
Oct-21-22Resumed Jefferies Buy $36
Jul-29-22Initiated CapitalOne Overweight $44
Jan-07-22Upgrade Piper Sandler Neutral → Overweight $21 → $28
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $21
Oct-05-20Upgrade Northland Capital Market Perform → Outperform $24
May-01-20Initiated Northland Capital Outperform $23
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Apr-04-24 05:50PM
Apr-01-24 06:00AM
Mar-27-24 09:30AM
Mar-26-24 05:50PM
Mar-20-24 05:50PM
09:30AM Loading…
Mar-11-24 09:30AM
Mar-08-24 11:31PM
Mar-06-24 11:29PM
04:05PM
Mar-02-24 08:24AM
Feb-29-24 08:09AM
Feb-28-24 05:25PM
05:12PM
04:25PM
04:05PM
02:09PM Loading…
Feb-23-24 02:09PM
Feb-22-24 05:45PM
09:30AM
Feb-21-24 06:54AM
Feb-20-24 04:01PM
Feb-16-24 08:00AM
Feb-15-24 05:45PM
Feb-09-24 05:45PM
Feb-05-24 05:50PM
12:41PM
Jan-30-24 05:50PM
Jan-23-24 05:50PM
Jan-17-24 05:50PM
Jan-11-24 05:50PM
Jan-05-24 05:50PM
06:00AM Loading…
Jan-02-24 06:00AM
Jan-01-24 12:00PM
Dec-27-23 09:30AM
Dec-25-23 08:23PM
12:45PM
Dec-21-23 08:00AM
Dec-08-23 12:45PM
Dec-05-23 12:00PM
Dec-04-23 03:02PM
Nov-30-23 06:13PM
Nov-29-23 09:30AM
Nov-22-23 12:45PM
Nov-21-23 01:03AM
Nov-20-23 04:20PM
Nov-17-23 11:04AM
Nov-16-23 05:10AM
Nov-13-23 09:30AM
Nov-10-23 03:43PM
01:15PM
Nov-09-23 04:05PM
01:27PM
08:38AM
05:42AM
Nov-08-23 04:05PM
Nov-01-23 04:10PM
Oct-31-23 05:45PM
06:43AM
Oct-30-23 05:50PM
Oct-23-23 05:50PM
Oct-16-23 05:50PM
Oct-10-23 09:40AM
Oct-09-23 05:50PM
Oct-02-23 05:50PM
Sep-25-23 05:50PM
Sep-19-23 05:50PM
Sep-14-23 09:30AM
Sep-13-23 05:50PM
12:37AM
Sep-11-23 04:05PM
Sep-09-23 01:01AM
Aug-31-23 04:05PM
Aug-18-23 01:54PM
Aug-14-23 07:01AM
Aug-11-23 12:45PM
10:33AM
09:40AM
Aug-10-23 09:15AM
Aug-09-23 07:18AM
Aug-08-23 08:30PM
07:19PM
04:05PM
Aug-02-23 04:10PM
Jul-28-23 08:02AM
Jul-26-23 05:50PM
12:00PM
Jul-25-23 07:42AM
Jul-23-23 08:27AM
Jul-20-23 05:50PM
05:01AM
Jul-19-23 09:10AM
Jul-17-23 08:40PM
Jul-14-23 05:50PM
Jul-12-23 12:45PM
Jul-11-23 09:40AM
Jul-10-23 08:12AM
Jul-07-23 08:41AM
Jul-05-23 12:00PM
Jun-30-23 04:05PM
01:21PM
Jun-26-23 12:45PM
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petersen Floyd F.DirectorApr 01 '24Sale43.4350021,71479,333Apr 02 09:31 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMar 15 '24Option Exercise12.46722,0468,996,6932,858,043Mar 19 06:55 PM
Zhang Jack Y.CEO & Chief Scientific OfficerMar 15 '24Option Exercise12.46310,9303,874,1881,439,466Mar 19 06:55 PM
PETERS WILLIAM JCFO, EVP & TREASURERMar 06 '24Option Exercise11.338,82699,999129,626Mar 08 04:52 PM
PETERS WILLIAM JCFO, EVP & TREASURERMar 06 '24Sale46.4818,136842,883111,490Mar 08 04:52 PM
ZASLOFF MICHAEL ADirectorMar 05 '24Sale47.1812,500589,72421,326Mar 06 05:57 PM
Petersen Floyd F.DirectorMar 01 '24Sale45.6950022,84779,833Mar 04 08:35 PM
Petersen Floyd F.DirectorFeb 01 '24Sale53.1050026,54880,333Feb 02 07:37 PM
Luo Mary Z.COO,Chief Scientist & ChairmanJan 10 '24Sale54.59131,3867,171,7681,104,416Jan 11 04:37 PM
Luo Mary Z.COO,Chief Scientist & ChairmanJan 09 '24Sale57.1486,1564,923,2321,235,802Jan 10 06:27 PM
Luo Mary Z.COO,Chief Scientist & ChairmanJan 08 '24Sale58.93133,6447,875,4761,321,958Jan 10 06:27 PM
Petersen Floyd F.DirectorJan 02 '24Sale61.3750030,68380,833Jan 03 07:25 PM
Zhou RongSenior EVP, Production CenterDec 04 '23Option Exercise16.193,51456,892115,934Dec 05 06:25 PM
Zhou RongSenior EVP, Production CenterDec 04 '23Sale59.583,514209,364112,420Dec 05 06:25 PM
Zhou RongSenior EVP, Production CenterDec 01 '23Option Exercise14.404,31662,150116,736Dec 05 06:25 PM
Zhou RongSenior EVP, Production CenterDec 01 '23Sale58.584,316252,831112,420Dec 05 06:25 PM
Petersen Floyd F.DirectorDec 01 '23Sale57.9050028,95281,333Dec 04 08:49 PM
PRINS RICHARD KDirectorNov 17 '23Sale55.864,000223,44631,895Nov 20 05:23 PM
PETERS WILLIAM JCFO, EVP & TreasurerNov 14 '23Option Exercise15.6159,250925,028160,610Nov 16 04:05 PM
PETERS WILLIAM JCFO, EVP & TreasurerNov 14 '23Sale55.6759,2503,298,475101,360Nov 16 04:05 PM
Deflin GayleDirectorNov 14 '23Sale55.454,163230,8382,716Nov 15 04:30 PM
PRINS RICHARD KDirectorNov 13 '23Sale52.505,000262,50035,895Nov 15 04:31 PM
Petersen Floyd F.DirectorNov 01 '23Sale45.3050022,65181,833Nov 02 08:37 PM
Petersen Floyd F.DirectorOct 02 '23Sale45.7850022,89082,333Oct 03 06:38 PM
PETERS WILLIAM JCFO, EVP & TreasurerSep 06 '23Option Exercise16.9356,500956,795162,103Sep 08 04:08 PM
PETERS WILLIAM JCFO, EVP & TreasurerSep 06 '23Sale51.7560,7433,143,195101,360Sep 08 04:08 PM
Liawatidewi YakobEVP Corp Admin CenterAug 28 '23Option Exercise14.8628,816428,09598,485Aug 29 06:54 PM
Liawatidewi YakobEVP Corp Admin CenterAug 28 '23Sale53.1328,8161,530,99469,669Aug 29 06:54 PM
PRINS RICHARD KDirectorAug 18 '23Sale52.502,000105,00640,895Aug 21 04:05 PM
ZASLOFF MICHAEL ADirectorAug 15 '23Sale57.2212,759730,02533,826Aug 16 08:23 PM
PRINS RICHARD KDirectorAug 15 '23Sale57.394,163238,91142,895Aug 16 08:22 PM
Zhou RongEVP, Production CenterJun 20 '23Option Exercise11.339,651109,346112,341Jun 21 05:05 PM
PETERS WILLIAM JCFO, EVP & TreasurerJun 15 '23Option Exercise19.7936,868729,618142,471Jun 20 04:01 PM
Zhou RongEVP, Production CenterJun 15 '23Option Exercise14.6419,377283,672102,690Jun 20 04:05 PM
PETERS WILLIAM JCFO, EVP & TreasurerJun 15 '23Sale50.8536,8681,874,790105,603Jun 20 04:01 PM
Zhou RongEVP, Production CenterJun 15 '23Sale51.795,000258,94696,888Jun 20 04:05 PM
Zhou RongEVP, Production CenterJun 13 '23Option Exercise14.405,00072,00093,313Jun 14 05:36 PM
Zhou RongEVP, Production CenterJun 13 '23Sale48.245,000241,20088,313Jun 14 05:36 PM
PETERS WILLIAM JCFO, EVP & TreasurerJun 02 '23Option Exercise13.3511,000146,850116,603Jun 05 05:06 PM
PETERS WILLIAM JCFO, EVP & TreasurerJun 02 '23Sale46.3511,000509,859105,603Jun 05 05:06 PM
Lee HowardDirectorJun 01 '23Option Exercise16.6916,679278,373159,618Jun 05 04:18 PM
Lee HowardDirectorJun 01 '23Sale45.0216,679750,960142,939Jun 05 04:18 PM
Zhou RongEVP, Production CenterMay 18 '23Option Exercise14.4010,000144,00097,598May 19 06:36 PM
PETERS WILLIAM JCFO, EVP & TreasurerMay 18 '23Option Exercise13.3510,500140,175115,648May 22 06:49 PM
PETERS WILLIAM JCFO, EVP & TreasurerMay 18 '23Sale44.3510,500465,675105,148May 22 06:49 PM
Zhou RongEVP, Production CenterMay 18 '23Sale44.2010,000442,05087,598May 19 06:36 PM
Deflin GayleDirectorMay 18 '23Sale44.014,519198,8884,163May 19 06:30 PM
Petersen Floyd F.DirectorMay 17 '23Sale43.135,000215,65580,117May 18 04:52 PM
PRINS RICHARD KDirectorMay 15 '23Option Exercise16.695,00083,45049,342May 16 07:59 PM
ZASLOFF MICHAEL ADirectorMay 15 '23Sale42.187,500316,33543,869May 16 08:01 PM
PRINS RICHARD KDirectorMay 15 '23Sale43.505,000217,50244,342May 16 07:59 PM
Deflin GayleDirectorMay 15 '23Sale43.151,50064,7288,682May 17 04:05 PM
PRINS RICHARD KDirectorMay 12 '23Option Exercise16.695,00083,45052,342May 16 07:59 PM
PRINS RICHARD KDirectorMay 12 '23Sale42.065,000210,32247,342May 16 07:59 PM